Citation Impact

Citing Papers

Allergen immunotherapy for asthma
2003
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Modest increase in seasonal allergic rhinitis and eczema over 8 years among Estonian schoolchildren
2005
DIAGNOSTIC TESTING FOR COMMUNITY-ACQUIRED PNEUMONIA
1999
Immunotherapy in asthma: an updated systematic review
1999
Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria‐induced respiratory allergy: a randomized controlled trial†
2004
Dietary Fish Oil Effects on Seasonal Hay Fever and Asthma in Pollen-sensitive Subjects
1993
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Specific immunotherapy in house dust mite allergy
1995
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
1998 Standout
Are asthma and allergies in children and adolescents increasing? Results from ISAAC phase I and phase III surveys in Münster, Germany
2003
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
A Longitudinal Test of the Theory of Planned Behavior Predicting Smoking Onset among Asthmatic and Non-asthmatic Adolescents
2007
Nonspecific and specific bronchial responsiveness in occupational asthma caused by platinum salts after allergen avoidance.
1994
Specific immunotherapy in asthma: Is it effective?
1994
Guidelines for Methacholine and Exercise Challenge Testing—1999
2000 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Pulmonary Function Tests in Preschool Children with Cystic Fibrosis
2002
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Prospective prediction of health-related behaviours with the Theory of Planned Behaviour: a meta-analysis
2011 Standout
Comparison of PCR, Culture, and Serological Tests for Diagnosis of Mycoplasma pneumoniae Respiratory Tract Infection in Children
1999
Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory
1997
The Asthma Epidemic
2006 Standout
Immunotherapy as an effective tool in allergy treatment
1998
Evaluation of Real-Time PCR for Detection of and Discrimination between Bordetella pertussis , Bordetella parapertussis , and Bordetella holmesii for Clinical Diagnosis
2003
Allergenic pollen and pollen allergy in Europe
2007 Standout
Diagnosis of Mycoplasma pneumoniae Pneumonia in Children
1998
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout

Works of HP Van Bever being referenced

Functional residual capacity in healthy preschool children
1996
Detection of Mycoplasma pneumoniae by Two Polymerase Chain Reactions and Role of M. pneumoniae in Acute Respiratory Tract Infections in Pediatric Patients
1996
Gender differences in respiratory, nasal and skin symptoms: 6-7 versus 13-14-year-old children
1999
Gender differences in respiratory, nasal and skin symptoms: 6–7 versus 13–14‐year‐old children
1999
Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus)
1992
Rankless by CCL
2026